IDEAYA Biosciences
IDYA
29 hedge funds and large institutions have $83.6M invested in IDEAYA Biosciences in 2019 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 7 closing their positions.
71% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 7
69% more capital invested
Capital invested by funds: $49.5M → $83.6M (+$34.2M)
27.41% more ownership
Funds ownership: 27.44% → 54.85% (+27%)
21% more funds holding
Funds holding: 24 → 29 (+5)
50% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$250K |
| 2 |
OGC
One68 Global Capital
New York
|
+$199K |
| 3 |
6CM
683 Capital Management
New York
|
+$160K |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$144K |
| 5 |
AIM
Alambic Investment Management
Belvedere,
California
|
+$141K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$3.81M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$1.32M |
| 3 |
Goldman Sachs
New York
|
-$306K |
| 4 |
Millennium Management
New York
|
-$167K |
| 5 |
LCM
Laurion Capital Management
New York
|
-$156K |
IDYA Hedge Fund Activity: Q4 2019 in Review
29 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in IDEAYA Biosciences (IDYA) for Q4 2019, worth a combined $83.6M — up 69% from $49.5M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new IDYA positions and 7 closed out — a net gain of 5 holders — while 3 added to existing stakes and 6 trimmed.
The largest buyer was Bridgeway Capital Management, adding an estimated $250K. The largest seller was Deerfield Management, exiting entirely with an estimated $3.81M sold.
- 29 institutional investors held IDEAYA Biosciences (IDYA) as of Q4 2019, up from 24 in Q3 2019.
- Funds reported $83.6M of IDEAYA Biosciences stock for Q4 2019, up 69% quarter-over-quarter.
- 12 funds opened new IDEAYA Biosciences positions in Q4 2019 and 7 closed out, a net change of +5 holders.
- The largest IDEAYA Biosciences buyer in Q4 2019 was Bridgeway Capital Management, an estimated $250K added.
- The largest IDEAYA Biosciences seller in Q4 2019 was Deerfield Management, an estimated $3.81M sold.
Based on aggregated 13F filings for Q4 2019.